Shandong Xinhua Pharmaceutical Announces Final Dividend for 2024

Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) has issued an update.

Shandong Xinhua Pharmaceutical Company Limited has announced a final cash dividend of RMB 0.25 per share for the financial year ending December 31, 2024. The dividend, payable in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.092519, will be distributed on July 18, 2025, following shareholder approval on June 13, 2025. The announcement also details the withholding tax rates applicable to different categories of shareholders, with non-resident enterprises subject to a 10% tax and resident individuals subject to a 20% tax. This dividend announcement reflects the company’s financial health and commitment to returning value to its shareholders, potentially enhancing its attractiveness to investors.

More about Shandong Xinhua Pharmaceutical Company Limited Class H

Shandong Xinhua Pharmaceutical Company Limited operates in the pharmaceutical industry, focusing on the production and distribution of a wide range of pharmaceutical products. The company is known for its development and manufacturing of active pharmaceutical ingredients and finished dosage forms, serving both domestic and international markets.

Average Trading Volume: 4,632,376

Technical Sentiment Signal: Buy

Current Market Cap: HK$9.69B

Find detailed analytics on 0719 stock on TipRanks’ Stock Analysis page.